BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 8380870)

  • 1. Naloxone does not reverse the inhibitory effect of morphine on luteinizing hormone secretion in prepubescent male rats.
    Cicero TJ; Nock B; O'Connor L
    J Pharmacol Exp Ther; 1993 Jan; 264(1):47-53. PubMed ID: 8380870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related differences in the sensitivity of serum luteinizing hormone to prototypic mu, kappa and delta opiate agonists and antagonists.
    Cicero TJ; Meyer ER; Miller BT; Bell RD
    J Pharmacol Exp Ther; 1988 Jul; 246(1):14-20. PubMed ID: 2839658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid-induced suppression of rat testicular function.
    Adams ML; Sewing B; Forman JB; Meyer ER; Cicero TJ
    J Pharmacol Exp Ther; 1993 Jul; 266(1):323-8. PubMed ID: 8392556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ontogeny of the opioid-mediated control of reproductive endocrinology in the male and female rat.
    Cicero TJ; Schmoeker PF; Meyer ER; Miller BT; Bell RD; Cytron SM; Brown CC
    J Pharmacol Exp Ther; 1986 Mar; 236(3):627-33. PubMed ID: 3512817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related differences in the sensitivity to opiate-induced perturbations in reproductive endocrinology in the developing and adult male rat.
    Cicero TJ; O'Connor L; Nock B; Adams ML; Miller BT; Bell RD; Meyer ER
    J Pharmacol Exp Ther; 1989 Jan; 248(1):256-61. PubMed ID: 2643703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opiate withdrawal-induced hyposensitivity to naloxone's effects on serum luteinizing hormone in the male rat.
    Cicero TJ; Aleem A; Meyer ER; Schmoeker PF; Miller BT
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1063-70. PubMed ID: 3528453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of multiple opiate receptors through neuroendocrine responses. II. Antagonism of mu, kappa and sigma agonists by naloxone and WIN 44,441-3.
    Pechnick R; George R; Poland RE
    J Pharmacol Exp Ther; 1985 Jan; 232(1):170-7. PubMed ID: 2981314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
    Eisenberg RM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):863-9. PubMed ID: 2989500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxone blocks the effects of delta 9-tetrahydrocannabinol on serum luteinizing hormone and prolactin in rats.
    Kumar MS; Simpkins JW
    Subst Alcohol Actions Misuse; 1983; 4(5):347-53. PubMed ID: 6322367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine exerts testosterone-like effects in the hypothalamus of the castrated male rat.
    Cicero TJ; Meyer ER; Gabriel SM; Bell RD; Wilcox CE
    Brain Res; 1980 Nov; 202(1):151-64. PubMed ID: 7427731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic naloxone treatment induces supersensitivity to a mu but not to a kappa agonist at the hypothalamus-pituitary-adrenocortical axis level.
    Alcaraz C; Vargas ML; Fuente T; Milanés MV
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1602-6. PubMed ID: 8396640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine-induced supersensitivity to the effects of naloxone on luteinizing hormone secretion in the male rat.
    Cicero TJ; Owens DP; Schmoeker PF; Meyer ER
    J Pharmacol Exp Ther; 1983 Apr; 225(1):35-41. PubMed ID: 6682144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of tolerance to the effects of morphine on luteinizing hormone secretion as a function of castration in the male rat.
    Cicero TJ; Meyer ER; Schmoeker PF
    J Pharmacol Exp Ther; 1982 Dec; 223(3):784-9. PubMed ID: 7143239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opiate-induced enhancement of the effects of naloxone on serum luteinizing hormone levels in the male rat: specificity for Mu agonists.
    Cicero TJ; Owens DP; Schmoeker PF; Meyer ER
    J Pharmacol Exp Ther; 1983 Sep; 226(3):770-5. PubMed ID: 6310081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro studies on the opioidergic control of the secretion of gonadotrophin-releasing hormone and luteinizing hormone in sexually immature and adult male rats.
    Leposavic G; Cover PO; Buckingham JC
    Neuroendocrinology; 1991 Jun; 53(6):579-88. PubMed ID: 1652110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioidergic, dopaminergic and adrenergic regulation of LH secretion in prepubertal heifers.
    Honaramooz A; Chandolia RK; Beard AP; Rawlings NC
    J Reprod Fertil; 2000 Jul; 119(2):207-15. PubMed ID: 10864832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine actions of opioids.
    Pfeiffer A; Herz A
    Horm Metab Res; 1984 Aug; 16(8):386-97. PubMed ID: 6088380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opiatergic control of gonadotropin secretion during puberty in the rat: a neurochemical basis for the hypothalamic 'gonadostat'?
    Bhanot R; Wilkinson M
    Endocrinology; 1983 Aug; 113(2):596-603. PubMed ID: 6409589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interrelationship between hormones, psychotropic drugs and the opiate receptor--a pilot study.
    Evans G; Groom GV
    Postgrad Med J; 1980; 56 Suppl 1():65-9. PubMed ID: 6248846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alcohol on the hypothalamic-pituitary-gonadal axis in the developing male rat.
    Little PJ; Adams ML; Cicero TJ
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1056-61. PubMed ID: 1469619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.